When Should We Use SGLT2 Inhibitors?
For more information, check out these great cases on https://www.francefoundation.com/education/disease-area/diabetes
Presented by:
John E. Gerich, MD
University of Rochester School of Medicine
Steven Wittlin, MD
University of Rochester School of Medicine
Видео When Should We Use SGLT2 Inhibitors? канала The France Foundation
Presented by:
John E. Gerich, MD
University of Rochester School of Medicine
Steven Wittlin, MD
University of Rochester School of Medicine
Видео When Should We Use SGLT2 Inhibitors? канала The France Foundation
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Using SGLT2-inhibitors to treat cardiac patients with diabetes
Pharmacology - DRUGS FOR DIABETES (MADE EASY)
Dr.Sanjay Kalra(Karnal), SGLT2 Inhibitors- Myths & Facts
Introduction to SGLT2 Inhibition
Dr. John McMurray: New and emerging heart failure therapies
Invokana, Farxiga, Jardiance, & Steglatro. What are SGLT-2 inhibitors?
SGLT-2 Inhibitors for Type 2 Diabetes - Amel Arnaout, MD
How does sitagliptin work? DPP-4 inhibitors and GLP-1 mimetics
Professor Milton Packer - 'Heart failure – are there limits to anti-diabetic therapy with SGLT2'
DPP-4 Inhibitors | Dr. Shantanu R. Joshi | 2019
Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidney?'
Professor Stephen Wiviott - 'SGLT2 Outcome trials - an evolving story'
Mercodia Webinar: Dr. Ralph DeFronzo: Glucagon Release with SGLT2 Inhibition
SGLT-2 inhibitors and DKA
SGLT2 Inhibition for the Prevention and Treatment of Kidney Disease in Patients With Type 2 Diabetes
Do SGLT-2 Inhibitors Reduce Risk of Heart Failure? Doctors Discuss SGLT2 Inhibitor Empagliflozin.
Gliptin Symposium(Sitagliptin): Drs Mohan, Shashank J, Krishna Sheshadri, A K Singh..
Glucose Transporters (GLUTs and SGLTs) - Biochemistry Lesson
How SGLT-2 Inhibitors Work: with Pros and Cons - Jardiance, Farxiga, Invokana -Type 2 Diabetes#15
Webinar: SGLT2 inhibitors in clinical practice